Executive Director, Project Management, Oncology
Cheryl Chapman, RN, is Executive Director of Project Management at Worldwide Clinical Trials. She has spent more than 20 years in the drug development industry and the last 14 years in project management, prominently in oncology. During her tenure, she has managed all phases of clinical research, including early phase dose escalation studies to large global programs. She has worked with a broad range of investigative treatments, including monoclonal antibodies, nucleotide DNA inhibitors, targeted therapies, orphan drugs, and oncolytic vaccines.
ABOUT CHERYL CHAPMAN
Of Cheryl Chapman’s two decades in clinical research, she has spent more than 14 years in study project management, prominently in oncology. Among her many achievements, she has the distinction of serving as lead project manager on what was, at the time, the largest-ever global breast cancer study, investigating almost 10,000 patients at 381 sites in 22 countries. She has been involved with a broad range of hematological malignancy and solid tumor indications involving various treatment modalities, including monoclonal antibodies, nucleotide DNA inhibitors, targeted therapies, orphan drugs, and oncolytic vaccines. She has managed all phases of oncology development from early phase dose escalation studies to large global programs. She has built her clinical and project management expertise through an array of clinical research responsibilities, including roles as research nurse, study site manager, clinical research associate, study manager, and program manager. Earlier in her career, she worked in a hospital-based clinical research unit overseeing setup and then managing a clinical research unit within a hospital respiratory department.
Cheryl studied nursing at North Staffordshire School of Nursing and is qualified in the United Kingdom as a Registered Nurse.